KENNEWICK, Wash., Aug. 1, 2008 (PRIME NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (Pink Sheets: ADMD) (http:www.isotopeworld.com) announced that it is preparing to file a registration statement on Form 10 with the Securities and Exchange Commission ("SEC"). Advanced Medical recently completed an audit of its financial statements and has engaged Sichenzia Ross Friedman Ference ("SRFF") to prepare its Form 10. After the Form 10 is filed and becomes effective, AMIC will become a public reporting company and will be required to file annual, quarterly and current reports as well as other information with the SEC.
James C. Katzaroff, CEO and Chairman, said, "The retention of SRFF and the subsequent filing of the Form 10 is a noteworthy step for the Company to become a fully reporting company and to have its stock quoted on the OTC Bulletin Board. AMIC is committed to providing accurate and timely information to its stakeholders as events materialize and we continue to penetrate supplying the international medical isotope marketplace."
About Sichenzia Ross Friedman Ference
Sichenzia Ross Friedman Ference LLP ("SRFF") provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF's clients range from start-ups to established listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. The firm's practice includes the representation of clients located in the the United States and throughout the world, including Argentina, Austria, Australia, Canada, China, Germany, Hungary, Israel, Korea, Malaysia, Mexico, Switzerland and the United Kingdom. For more information visit http://www.srff.com
About Advanced Medical Isotope Corporation
Advanced Medical Isotope Corporation (AMIC) is a medical isotope production company engaged in the production and distribution of medical isotopes and medical isotope in vivo delivery systems for advanced diagnostic and non-surgical therapeutic applications. AMIC's goal is to empower physicians, medical researchers, and ultimately patients by providing them with essential medial isotopes that, until now, have not been feasible or economical, in an effort to detect and cure human disease. For more information, please visit our website, http://www.isotopeworld.com
The Advanced Medical Isotope Corporation logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=5139